![[D-Lys6]-LH-RH](https://file.medchemexpress.com/product_pic/hy-p3668.gif "Click to View [D-Lys6]-LH-RH Product Detail")
![[D-Lys6]-LH-RH TFA](https://file.medchemexpress.com/product_pic/hy-p3668a.gif "Click to View [D-Lys6]-LH-RH TFA Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
58 Results for "
D6D
" in MedChemExpress (MCE) Product Catalog:
Products (58)
58 Results for "D6D" in MCE Product Catalog:
5
5 Cited Publications
Target:
Research Areas:
SC-26196 is a potent, orally active Delta6 desaturase (D6D, FADS2) inhibitor (IC50=0.2 μM in a rat liver microsomal assay). Antiinflammatory properties .
2
2 Cited Publications
Target:
Research Areas:
D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor, with IC50s of 72 and 22 nM for rat and human D5D in enzymic and cell-based assays, respectively, has no effect on D6D or D9D activity. D5D-IN-326 reduces insulin resistance and decreases body weight in diet-induced obese C57BL/6J mice .
1
1 Cited Publications
Target:
Research Areas:
T-3364366 is a reversible, slow-binding, thienopyrimidinone delta-5 desaturase (D5D) inhibitor with IC50s of 1.9 nM and 2.1 nM in HepG2 and RLN-10 cells, respectively. T-3364366 exhibits potent D5D (IC500=19 nM) inhibitory activity and excellent selectivity away from delta-6 desaturase (D6D, IC50=6200 nM) and delta-9 desaturase (stearoyl-CoA desaturase, SCD,50 >10000 nM) in the enzymatic activity assay .
Cat. No.: HY-P3668
CAS No.: 52671-12-2
Target:
Research Areas:
Cat. No.: HY-W017018S
CAS No.: 347841-40-1
Cat. No.: HY-Y0124S
CAS No.: 50348-93-1
Synonyms: α,α-Dimethylglycine-d6; α-Aminoisobutanoic acid-d6
Synonyms: MK 733-d6
Cat. No.: HY-P3668A
Target:
Research Areas:
Cat. No.: HY-W048995
CAS No.: 72002-30-3
Target:
Research Areas:
D-6-Oxo-pipecolinic acid is the D-enantiomer of 6-Oxo-pipecolinic acid. 6-Oxo-pipecolinic acid is the biomarkers associated with pyridoxine-dependent epilepsy (PDE-ALDH7A1) .
Cat. No.: HY-17504AS1
CAS No.: 2070009-40-2
Synonyms: ZD 4522-d6
Cat. No.: HY-RS04667
Target:
Research Areas:
FADS2 Human Pre-designed siRNA Set A contains three designed siRNAs for FADS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-W105506S
CAS No.: 1246274-70-3
Synonyms: s,s-Dimethyl-β-propionic acid thetine-d6
Synonyms: BIBW 2992 d6
Cat. No.: HY-Y0504S4
CAS No.: 347840-14-6
Synonyms: Hegzadesil-d6; Trimethylamine hydrochloric acid-d6; Trimethylamine monohydrochloride-d6
Cat. No.: HY-11018S2
CAS No.: 1225444-65-4
Synonyms: R 64 766-d6
Cat. No.: HY-W050088S
CAS No.: 2012598-71-7
Synonyms: HP 549-d6
Cat. No.: HY-107410R
CAS No.: 218136-59-5
Research Areas:
SC-26196 (Standard) is the analytical standard of SC-26196 (HY-107410). This product is intended for research and analytical applications. SC-26196 is a potent, orally active Delta6 desaturase (D6D, FADS2) inhibitor (IC50=0.2 μM in a rat liver microsomal assay). Antiinflammatory properties .
Cat. No.: HY-13511S
Synonyms: UR-12592-d6
Cat. No.: HY-18318
CAS No.: 1125632-93-0
Takeda-6D (compound 6d) is an orally active and potent BRAF/VEGFR2 inhibitor, with IC50 values of 7.0 and 2.2 nM, respectively. Takeda-6D shows antiangiogenesis by suppressing the VEGFR2 pathway in 293/KDR and VEGF-stimulated HUVEC cells.Takeda-6D shows significant suppression of ERK1/2 phosphorylation. Takeda-6D shows antitumor activity .
Cat. No.: HY-W021399S
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
